Fitch Downgrades Pfizer's IDR, Upgrades Wyeth's Ratings Following Completion of Acquisition - Press Release - 2009/10/15 - Fitch Research

Report title: Fitch Downgrades Pfizer's IDR, Upgrades Wyeth's Ratings Following Completion of Acquisition

from Fitch Research
980 word report published Oct 15, 2009

Price $85.00 available for immediate download

Report Overview

Search Inside

About Fitch Research

Fitch Downgrades Pfizer's IDR, Upgrades Wyeth's Ratings Following Completion of Acquisition 15 Oct 2009 3:56 PM (EDT) Fitch Ratings-Chicago-15 October 2009: As a result of Pfizer Inc.'s (Pfizer) completed acquisition of Wyeth today for...

Report Type:

Press Release

Company(ies):

Pfizer Inc., Wyeth

Ticker(s):

PFE

Free Sample:

Click Here to Download

Format:

HTML

Enter the keyword(s) which you would like to search for within this document and click "Search"

Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

Also from Fitch Research

Fitch: Pension Contributions Remain a Credit Concern for U.S. Corporate Issuers in 2009/10 $85.00
U.S. Healthcare Stats Quarterly -- Second-Quarter 2009 $275.00
Global Pharmaceutical R&D Pipeline (Second-Quarter 2009) $275.00
U.S. Pharmaceutical Industry -- International Tax Reform $275.00
Global Pharmaceutical R&D Pipeline (First-Quarter 2009) $275.00
Fitch Rates Pfizer, Inc.'s Debt Offering 'AA' $85.00
Credit Update: Wyeth $165.00
Credit Update: Pfizer, Inc. $165.00

Price: $85.00

Free Sample

Questions about
this research?

Send page to a friend

Return to
Alacra Company Snapshot

Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.